Sources | Names Used |
---|---|
CTRPv2 | BRD-K27188169:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-K27188169:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF625 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | C4orf46 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
mRNA | BRPF1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | SH2B1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | HTRA3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | DOLK | CTRPv2 | pan-cancer | AAC | -0.15 | 0.01 |
mRNA | TIGD5 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | AUP1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | CDC14B | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
mRNA | CTD-2561J22.3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |